NCT06665737View on ClinicalTrials.gov

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 27, 2026

Study Completion Date

December 31, 2026

Conditions
Non-Hodgkin's Lymphoma (NHL)Granulocyte Colony Stimulating FactorFebrile Neutropenia (FN)Myelosuppression Adult
Interventions
DRUG

Early receiving G-CSF group

Early receiving G-CSF group will be given within 72 hours post chemotherapy

DRUG

Late receiving G-CSF group

Late receiving G-CSF group will be given after 72 hours post chemotherapy

Trial Locations (3)

10400

Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok

Rajavithi Hospital, Bangkok

11000

Internal Medicine Unit, Pranongklao Hospital, Nontaburi

All Listed Sponsors
collaborator

Mahidol University

OTHER

collaborator

Internal Medicine Unit, Pranangklao Hospital

UNKNOWN

lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV